Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
43.19
+1.48 (3.55%)
At close: Sep 17, 2026, 4:00 PM EDT
43.37
+0.18 (0.42%)
Pre-market: Sep 18, 2026, 5:45 AM EDT

Novo Nordisk Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of $47.22. The average 1-year stock price forecast is 9.33% higher than the current stock price, while the lowest is $39.91 (-7.59%) and the highest is $64.03 (+48.25%).

Price Target: $47.22 (+9.33%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$39.91$47.22$45.14$64.03
Change-7.59%+9.33%+4.51%+48.25%

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy444433
Buy110000
Hold9910101110
Sell000000
Strong Sell000001
Total141414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BMO Capital
BMO Capital
Hold
Maintains
$47
HoldMaintains$47+8.82%Sep 14, 2026
Morgan Stanley
Morgan Stanley
Sell
Downgrades
$40
SellDowngrades$40-7.39%Sep 11, 2026
Berenberg Bank
Berenberg Bank
Hold
Downgrades
$50$47
HoldDowngrades$50$47+8.82%Aug 12, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
$48$44
HoldMaintains$48$44+1.88%Aug 7, 2026
Argus Research
Argus Research
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
299.71B
from 309.06B
Decreased by -3.03%
Revenue Next Year
304.05B
from 299.71B
Increased by 1.45%
EPS This Year
21.50
from 23.03
Decreased by -6.64%
EPS Next Year
21.84
from 21.50
Increased by 1.56%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
140.80B176.95B232.26B290.40B309.06B299.71B
Revenue Growth
10.91%25.68%31.26%25.03%6.43%-3.03%
Gross Profit
117.14B148.53B196.94B246.84B254.69B239.41B
Gross Margin
83.20%83.94%84.79%85.00%82.41%79.88%
Operating Income
59.22B75.62B104.70B138.90B140.62B123.04B
Net Income
47.76B55.53B83.68B100.99B102.43B98.19B
EPS
----23.0321.50
EPS Growth
----1.77%-6.64%
Forward PE
-----13.08
Dividend / Share
5.206.209.4011.4011.7011.29
Dividend Growth
14.29%19.23%51.61%21.28%2.63%-3.49%
Free Cash Flow
43.90B57.50B54.55B60.57B376.88M56.63B
No. Analysts
-----27
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High333.8B
Avg299.7B
Low272.7B

Revenue Growth

Revenue Growth202620272028
High
8.0%
Avg
-3.0%
Low
-11.8%

EPS Forecast

EPS202620272028
High23.60
Avg21.50
Low18.59

EPS Growth

EPS Growth202620272028
High
2.5%
Avg
-6.6%
Low
-19.3%